These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29845418)

  • 1. End-of-life chemotherapy is associated with poor survival and aggressive care in patients with small cell lung cancer.
    Zhu Y; Tang K; Zhao F; Zang Y; Wang X; Li Z; Sun X; Yu J
    J Cancer Res Clin Oncol; 2018 Aug; 144(8):1591-1599. PubMed ID: 29845418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy Near the End of Life for Chinese Patients with Solid Malignancies.
    Sheng J; Zhang YX; He XB; Fang WF; Yang YP; Lin GN; Wu X; Li N; Zhang J; Zhai LZ; Zhao YY; Huang Y; Zhou NN; Zhao HY; Zhang L
    Oncologist; 2017 Jan; 22(1):53-60. PubMed ID: 27789776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative Chemotherapy Near the End of Life in Oncology Patients.
    Zhang Z; Chen ML; Gu XL; Liu MH; Zhao WW; Cheng WW
    Am J Hosp Palliat Care; 2018 Sep; 35(9):1215-1220. PubMed ID: 29529885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latent class analysis identifies three subtypes of aggressive end-of-life care: a population-based study in Taiwan.
    Chen ML; Chen YY; Tang ST
    Eur J Cancer; 2013 Oct; 49(15):3284-91. PubMed ID: 23756054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants for aggressive end-of-life care for oral cancer patients: a population-based study in an Asian country.
    Chang TS; Su YC; Lee CC
    Medicine (Baltimore); 2015 Jan; 94(4):e460. PubMed ID: 25634186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Targeted Therapy on the Quality of End-of-Life Care for Patients With Non-Small-Cell Lung Cancer: A Population-Based Study in Taiwan.
    Tsai HY; Chung KP; Kuo RN
    J Pain Symptom Manage; 2018 Mar; 55(3):798-807.e4. PubMed ID: 29056563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Associated With Aggressiveness of End-of-Life Care for Lung Cancer Patients and Associated Costs of Care.
    Bylicki O; Rivière F; Tournier C; Canoui-Poitrine F; Grassin F; Margery J; Prodel M; Vainchtock A; Assié JB; Chouaïd C
    Clin Lung Cancer; 2021 May; 22(3):e320-e328. PubMed ID: 32646653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escalating Health Care Expenditures in Cancer Decedents' Last Year of Life: A Decade of Evidence from a Retrospective Population-Based Cohort Study in Taiwan.
    Hung YN; Liu TW; Wen FH; Chou WC; Tang ST
    Oncologist; 2017 Apr; 22(4):460-469. PubMed ID: 28232596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between survival time with metastatic breast cancer and aggressive end-of-life care.
    Accordino MK; Wright JD; Vasan S; Neugut AI; Gross T; Hillyer GC; Hershman DL
    Breast Cancer Res Treat; 2017 Nov; 166(2):549-558. PubMed ID: 28752188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective Analysis.
    Genestreti G; Tiseo M; Kenmotsu H; Kazushige W; Di Battista M; Cavallo G; Carloni F; Bongiovanni A; Burgio MA; Casanova C; Metro G; Scarpi E; Korkmaz T; Selcuk S; Roopa K; Califano R
    Clin Lung Cancer; 2015 Nov; 16(6):e223-8. PubMed ID: 25983005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of aggressive end-of-life care for Taiwanese cancer decedents, 2001 to 2006.
    Tang ST; Wu SC; Hung YN; Chen JS; Huang EW; Liu TW
    J Clin Oncol; 2009 Sep; 27(27):4613-8. PubMed ID: 19704067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palliative Chemotherapy Affects Aggressiveness of End-of-Life Care.
    Wu CC; Hsu TW; Chang CM; Lee CH; Huang CY; Lee CC
    Oncologist; 2016 Jun; 21(6):771-7. PubMed ID: 27091417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of Efficacy and Safety of Different Therapeutic Regimens as 
Second-line Treatment for Small Cell Lung Cancer].
    Li Z; Liu X; Li J; Gao H; Tang C; Li X; Guo W; Qin H; Wang W; Qu L; Chen J
    Zhongguo Fei Ai Za Zhi; 2015 May; 18(5):280-8. PubMed ID: 25975298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Early Patient-Physician Care Planning Discussions and End-of-Life Care Intensity in Advanced Cancer.
    Ahluwalia SC; Tisnado DM; Walling AM; Dy SM; Asch SM; Ettner SL; Kim B; Pantoja P; Schreibeis-Baum HC; Lorenz KA
    J Palliat Med; 2015 Oct; 18(10):834-41. PubMed ID: 26186553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferences for Aggressive End-of-life Care and Their Determinants Among Taiwanese Terminally Ill Cancer Patients.
    Liu LN; Chen CH; Liu TW; Lin YC; Lee SC; Tang ST
    Cancer Nurs; 2015; 38(3):E9-E18. PubMed ID: 24915466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological factors at early stage of treatment as predictors of receiving chemotherapy at the end of life.
    Fujisawa D; Temel JS; Traeger L; Greer JA; Lennes IT; Mimura M; Pirl WF
    Psychooncology; 2015 Dec; 24(12):1731-7. PubMed ID: 25959002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of patients with small cell lung carcinoma in Taiwan.
    Kuo YH; Lin ZZ; Yang YY; Shao YY; Shau WY; Kuo RN; Yang JC; Lai MS
    Oncology; 2012; 82(1):19-24. PubMed ID: 22269348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low socioeconomic status is associated with more aggressive end-of-life care for working-age terminal cancer patients.
    Chang CM; Wu CC; Yin WY; Juang SY; Yu CH; Lee CC
    Oncologist; 2014 Dec; 19(12):1241-8. PubMed ID: 25342317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent Hospice Care and Cancer-Directed Treatment for Advanced Lung Cancer and Receipt of Aggressive Care at the End of Life in the Veteran's Health Administration.
    Presley CJ; Han L; O'Leary JR; Zhu W; Corneau E; Chao H; Shamas T; Rose M; Lorenz K; Levy CR; Mor V; Gross CP
    J Palliat Med; 2020 Aug; 23(8):1038-1044. PubMed ID: 32119800
    [No Abstract]   [Full Text] [Related]  

  • 20. Timing of end-of-life care discussion with performance on end-of-life quality indicators in ovarian cancer.
    Lopez-Acevedo M; Havrilesky LJ; Broadwater G; Kamal AH; Abernethy AP; Berchuck A; Alvarez Secord A; Tulsky JA; Valea F; Lee PS
    Gynecol Oncol; 2013 Jul; 130(1):156-61. PubMed ID: 23587882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.